FF — Fine Foods & Pharmaceuticals NTM SpA Income Statement
0.000.00%
Last trade - 00:00
- €212.13m
- €255.38m
- €251.81m
- 68
- 25
- 67
- 53
R2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 160 | 172 | 195 | 207 | 252 |
Cost of Revenue | |||||
Gross Profit | 46.7 | 48.6 | 56.1 | 54.5 | 68.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 152 | 162 | 190 | 208 | 251 |
Operating Profit | 8.15 | 9.48 | 5.03 | -1.01 | 1.07 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.115 | 16.7 | -4.59 | -14.2 | -1.86 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.79 | 13.4 | -1.43 | -9.5 | -3.52 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.79 | 13.4 | -1.43 | -9.5 | -3.52 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.79 | 13.4 | -1.43 | -9.5 | -3.52 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.095 | 0.591 | -0.024 | -0.345 | 0.005 |
Dividends per Share |